Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 59Carcinoma, Hepatocellular 46Colorectal Neoplasms 33Stomach Neoplasms 31Esophageal Squamous Cell Carcinoma 27Squamous Cell Carcinoma of Head and Neck 20Esophageal Neoplasms 14Small Cell Lung Carcinoma 13Neoplasm Metastasis 13Lung Neoplasms 13Rectal Neoplasms 12Head and Neck Neoplasms 12Advanced Solid Tumor 12Triple Negative Breast Neoplasms 11Cholangiocarcinoma 11Nasopharyngeal Carcinoma 10Melanoma 10Uterine Cervical Neoplasms 9Recurrence 9Neoplasms 9Colonic Neoplasms 9Pancreatic Neoplasms 7Urinary Bladder Neoplasms 6Solid Tumor 6Carcinoma, Transitional Cell 6Breast Neoplasms 6Sarcoma 5Lymphoma, Extranodal NK-T-Cell 5Lymphoma 5Hodgkin Disease 5

Interventions

Indocyanine Green 7Lymph Node Excision 6Surgical Procedures, Operative 5Radiotherapy, Intensity-Modulated 4Radiotherapy 4Radiosurgery 4Magnetic Resonance Spectroscopy 4Cisplatin 4Specimen Handling 3gadofosveset trisodium 2Technetium 2TP protocol 2Sentinel Lymph Node Biopsy 2Radiation Dose Hypofractionation 2Nivolumab 2Ipilimumab 2Electroporation 2Conversion to Open Surgery 2Control Groups 2Chemotherapy, Adjuvant 2Chemoradiotherapy 2Artificial Intelligence 2tislelizumab 1sarcolipin 1radium Ra 223 dichloride 1peposertib 1pembrolizumab 1lncRNA LNMAT1, human 1gewf solution 1fluoroazomycin arabinoside 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphatic Metastasis × tislelizumab × Clear all
NCT07353294 2026-04-22

Propranolol With Tislelizumab Plus GC in Neoadjuvant Bladder UC

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase 1 Enrolling by invitation
12 enrolled

Lymphatic Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡